NP40725 Erythropoietin Stimulating Agents

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Supply)
Duration
3 year (est.)
Value
£8M
Sector
HEALTH
Published
19 Nov 2025
Delivery
To 18 Nov 2028 (est.)
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 3 suppliers

2 buyers

3 suppliers

Description

Supply of Erythropoietin Stimulating Agents to NHS Scotland.

Total Quantity or Scope

The Authority intends to award this framework as a single supplier framework per line. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents. Include further framework-specific content if appropriate.

Award Detail

1 Roche Products (Welwyn Garden City)
  • Num offers: 3
  • Value: £8,493,876 [share]
  • Awarded to group of suppliers.
2 Pfizer (Tadworth)
  • Num offers: 3
  • Value: £8,493,876 [share]
  • Awarded to group of suppliers.
3 Amgen (Cambridge)
  • Num offers: 3
  • Value: £8,493,876 [share]
  • Awarded to group of suppliers.

Award Criteria

Supply Chain 5.0
PRICE 95.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

The estimated value(s) referred to in Section II.1.7 and V.2.4 cover(s) the thirty-six (36) month contract duration and the twelve (12) month extension period of the framework agreement. (SC Ref:816001)

Reference

Domains